These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Intravitreal triamcinolone acetonide as an additional tool in pars plana vitrectomy for proliferative diabetic retinopathy. Jonas JB; Söfker A; Degenring R Eur J Ophthalmol; 2003 Jun; 13(5):468-73. PubMed ID: 12841570 [TBL] [Abstract][Full Text] [Related]
49. Is the effect of intravitreal triamcinolone acetonide on diabetic macular edema dose-dependent? Šaric B; Šaric VB; Motušic R; Predovic J Eur J Ophthalmol; 2014; 24(2):221-7. PubMed ID: 24030541 [TBL] [Abstract][Full Text] [Related]
50. Catechin Weakens Diabetic Retinopathy by Inhibiting the Expression of NF-κB Signaling Pathway-Mediated Inflammatory Factors. Wang W; Zhang Y; Jin W; Xing Y; Yang A Ann Clin Lab Sci; 2018 Sep; 48(5):594-600. PubMed ID: 30373863 [TBL] [Abstract][Full Text] [Related]
51. Baicalein reduces inflammatory process in a rodent model of diabetic retinopathy. Yang LP; Sun HL; Wu LM; Guo XJ; Dou HL; Tso MO; Zhao L; Li SM Invest Ophthalmol Vis Sci; 2009 May; 50(5):2319-27. PubMed ID: 19011009 [TBL] [Abstract][Full Text] [Related]
52. HMGB1 siRNA can reduce damage to retinal cells induced by high glucose in vitro and in vivo. Jiang S; Chen X Drug Des Devel Ther; 2017; 11():783-795. PubMed ID: 28352154 [TBL] [Abstract][Full Text] [Related]
53. The role of apelin in the retina of diabetic rats. Lu Q; Feng J; Jiang YR PLoS One; 2013; 8(7):e69703. PubMed ID: 23874984 [TBL] [Abstract][Full Text] [Related]
54. Functional and structural effect of intravitreal indocyanine green, triamcinolone acetonide, trypan blue, and brilliant blue g on rat retina. Creuzot-Garcher C; Acar N; Passemard M; Bidot S; Bron A; Bretillon L Retina; 2010 Sep; 30(8):1294-301. PubMed ID: 20526232 [TBL] [Abstract][Full Text] [Related]
55. Subconjunctival Delivery of p75NTR Antagonists Reduces the Inflammatory, Vascular, and Neurodegenerative Pathologies of Diabetic Retinopathy. Galan A; Barcelona PF; Nedev H; Sarunic MV; Jian Y; Saragovi HU Invest Ophthalmol Vis Sci; 2017 Jun; 58(7):2852-2862. PubMed ID: 28570737 [TBL] [Abstract][Full Text] [Related]
56. Blocking IL-17A Alleviates Diabetic Retinopathy in Rodents. Qiu AW; Liu QH; Wang JL Cell Physiol Biochem; 2017; 41(3):960-972. PubMed ID: 28222445 [TBL] [Abstract][Full Text] [Related]
58. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy. Amin RH; Frank RN; Kennedy A; Eliott D; Puklin JE; Abrams GW Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):36-47. PubMed ID: 9008628 [TBL] [Abstract][Full Text] [Related]
59. AMA0428, A Potent Rock Inhibitor, Attenuates Early and Late Experimental Diabetic Retinopathy. Hollanders K; Hove IV; Sergeys J; Bergen TV; Lefevere E; Kindt N; Castermans K; Vandewalle E; van Pelt J; Moons L; Stalmans I Curr Eye Res; 2017 Feb; 42(2):260-272. PubMed ID: 27399806 [TBL] [Abstract][Full Text] [Related]
60. Anti-inflammatory role of sesamin in STZ induced mice model of diabetic retinopathy. Ahmad S; ElSherbiny NM; Jamal MS; Alzahrani FA; Haque R; Khan R; Zaidi SK; AlQahtani MH; Liou GI; Bhatia K J Neuroimmunol; 2016 Jun; 295-296():47-53. PubMed ID: 27235348 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]